Indian pharmaceutical industry is making significant strides with reports indicating positive outcomes in regulatory inspections by the USFDA. Emcure Pharma, backed by Bain Capital, is set to launch an IPO on July 3 with a price band of Rs 960-1008 per share. The Drug Controller General and Department of Pharmaceuticals project substantial growth for the Indian pharma sector, aiming to reach $130 billion by 2030. However, challenges persist as around 36% of drug manufacturing units in India have been ordered to shut down due to quality non-compliance.
#LeadStoryOnET | India wants to boost local mfg of diabetes, obesity drugs by 2026 https://t.co/oHFVyOMOIg
#OnETNOW | What's next for Wockhardt's FY25 product pipeline? Discover the growth prospects from Habil Khorakiwala talk to @AASTHACHOPRA13 of ET NOW! @dr_khorakiwala @WFIndia https://t.co/7YWcl4f7hI
#OnETNOW | What's next for Wockhardt's FY25 product pipeline? Discover the growth prospects from Founder Chairman Habil Khorakiwala talk to @AASTHACHOPRA13 of ET NOW! @dr_khorakiwala @WFIndia https://t.co/7YWcl4f7hI
#OnETNOW | Emcure Pharma's IPO opens next week! What are their plans for growth, debt reduction, and revenue boost? Catch Satish Mehta and Namita Thapar's insights on ET NOW! @EmcurePharma @namitathapar @SnehiShah11 @_sherylld https://t.co/8YmJHPg7ZX
India plans incentives for diabetes, obesity drug makers in 2026, government official says https://t.co/1vVomwx6gv https://t.co/AsHEITEi3V
India plans incentives for diabetes, obesity drug makers in 2026, government official tells @RishikaSadam @Reuters https://t.co/PigJHmsAIg
Emcure Pharmaceuticals has set a price band of Rs 960-1008 per share for its IPO that opens for subscription on July 3, seeking to raise up to Rs 1952 crore through a fresh issue of 7.9 million equity shares. @sohinidastweets #EmcurePharma #IPO https://t.co/Or2zGZyQiK
#Obesity, #diabetes #drugs’ #PLI scheme in #India soon: Report https://t.co/oHFVyOMgSI
Around 36% of the pharma manufacturing units inspected by the Indian drug regulator in recent times were forced to shut down due to non-compliance with quality standards. @sohinidastweets #Pharmaceuticals #manufacturing #India #Drugmakers #Pharmasector https://t.co/QVuSBXipxj
Namita Thapar's @EmcurePharma #IPO to hit Dalal Street on July 3: Check price band, other details https://t.co/H77Z2ke5HM
#Wockhardt in focus, co to hold a press conference at 12:30 pm today on WCK 5222 drug. Global Phase III clinical studies is progressing in 9 countries and is estimated to complete by end of FY25 Stock hits 5% upper circuit https://t.co/UjV6Gqg9Qi
IPO Alert | Emcure IPO price band of Rs 960-1008/sh; IPO size at Rs 1,952 cr @EmcurePharma https://t.co/rZP77vjPsi
CDSCO cracks whip on drug manufacturing units over quality lapses https://t.co/aRckDhqDtU
Indian regulator says 36% of inspected drug-making units had to be shut https://t.co/K3nslAz6oh https://t.co/SLgyoDXEKW
More than 36% of the 400 drug manufacturing units inspected since last year in India were ordered to be shut, the country's drug regulator said on Thursday. via @RishikaSadam @Reuters https://t.co/R64Gb9igkK
ET NOW Exclusive | "Indian pharma industry has achieved double digit growth in the last 10 years," says Arunish Chawla, Department of Pharmaceuticals Here's his take on the 'next revolution'👇 @Pharmadept @AASTHACHOPRA13 https://t.co/ZOtZppDVqM
#LeadStoryOnET | #Indian #pharma companies beat global average in outcomes of #regulatory #inspection by #USFDA https://t.co/SqAKPZNUaC
Indian Pharma Leading Way With USA - Report America's Food & Drug Administration classified 13% of inspections carried out in India as needing an Official Action Indication (OAI) - a number which is below the global average (15%) and half the amount in 2014. OAIs require… https://t.co/ii1uCN40oL https://t.co/6yHXqsv9k5
ET NOW Exclusive | "Indian pharma industry will hit $130 bn by 2030," says Drug Controller General Rajeev Raghuvanshi Here are his statements on the outlook for the pharma industry and importance of quality in the sector👇 @AASTHACHOPRA13 https://t.co/WJ4wK8Egoc
Bain Capital-backed Emcure Pharma To Float IPO On July 3, Check Issue Size and Other Details #emcure #Pharmaceutical #IPO https://t.co/HPnBGv8Mts